Lyell Immunopharma Inc (LYEL) — Defensive Interval Ratio
Lyell Immunopharma Inc (LYEL) has a Defensive Interval Ratio of 1382 days as of December 2025. Defensive assets of $187.04 Million (cash $-, short-term investments $187.04 Million, receivables $-) cover 1382 days of daily cash needs of $135.38K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lyell Immunopharma Inc Defensive Interval Ratio (2019–2025)
This chart shows how Lyell Immunopharma Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the ratio stands at 1382 days, meaning defensive assets of $187.04 Million can fund 1382 days of operations without new revenue. For the complete balance sheet picture, see Lyell Immunopharma Inc total assets.
Annual Defensive Interval Ratio for Lyell Immunopharma Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Lyell Immunopharma Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Lyell Immunopharma Inc (LYEL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1382 days | $187.04 Million | $135.38K/day | $- | $187.04 Million | ▼ -416 days |
| 2024 | 1798 days | $264.93 Million | $147.36K/day | $- | $264.93 Million | ▼ -2438 days |
| 2023 | 4236 days | $400.58 Million | $94.57K/day | $- | $400.58 Million | ▼ -857 days |
| 2022 | 5092 days | $516.60 Million | $101.45K/day | $- | $516.60 Million | ▲ +2586 days |
| 2021 | 2507 days | $320.97 Million | $128.05K/day | $- | $320.97 Million | ▼ -991 days |
| 2020 | 3497 days | $472.21 Million | $135.03K/day | $- | $472.21 Million | ▼ -2122 days |
| 2019 | 5619 days | $339.38 Million | $60.40K/day | $- | $339.38 Million | — |